VIPpharma ApS: Financial statements 2023
CVR: 38744763
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
VIPpharma ApS (CVR 38744763) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,584,996 and a net result of DKK 743,463 compared with DKK 633,504 the year before. That is an increase of 9.7% compared with the year before. Equity in the 2023 report amounted to DKK 1,747,060. The solvency ratio was 59.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,584,996
- Profit/Loss
- DKK 743,463
- Equity
- DKK 1,747,060
- Total Assets
- DKK 2,928,656
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.6 mio. | 743 t. | 1.7 mio. | 2 |
| 2022 | - | 2.4 mio. | 634 t. | 2 mio. | 2 |
| 2021 | - | 2.1 mio. | 428 t. | 2.4 mio. | 2 |
| 2020 | - | 2.2 mio. | 716 t. | 3.7 mio. | 2 |
| 2019 | - | 1.1 mio. | -173 t. | 3.1 mio. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
VIPpharma ApS has published its annual report for 2022. Gross profit came to DKK 2,357,487, and the net result was DKK 633,504.
About VIPpharma ApS
VIPpharma ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Public relations og kommunikation. The management consists of Vibeke Wærens. The company is owned by VIPinvest ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. Equity in the 2025 report amounted to DKK 1,263,395.